Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.08 – $1.75
40% from low
Exchange
OTC Link
OS
RYMAN HEALTHCARE ORD
No one on the platform currently holds RHCGF.
No tracked institution reports a position in RHCGF as of their last filing.
No one on the platform has traded RHCGF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $544M | +9.5% | $0.03 | $0.03–$0.04 | 40.1× | 1 |
| 2028 | $583M | +7.1% | $0.06 | $0.06–$0.07 | 21.9× | 1 |
| 2029 | $616M | +5.7% | $0.08 | $0.08–$0.10 | 16.1× | 1 |
| 2030 | $622M | +1.0% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2024-11-27 | $0.06 | $0.08 | +23.6% |
| 2023-12-14 | $0.14 | $0.15 | +5.4% |
| 2022-11-17 | $0.09 | $0.14 | +56.2% |
| +0.00% |
| $740M |
| — |
| MAHLYMediPal Holdings Corporation | $17.37 | +0.00% | $3.6B | — |
| MCVEFMedicover AB (publ) | $27.25 | +0.00% | $4.1B | — |
Source: Financial Modeling Prep · peers by sector/industry